| |
Latest 10 SEC filings (by transaction date) for YMAB within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 14/24 | Mar 12/24 | Tagliaferri Mary | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 27,900 | |
Mar 14/24 | Mar 12/24 | Tagliaferri Mary | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 4,660 | |
Mar 7/24 | Mar 5/24 | Rajah Vignesh | Direct Ownership | Common Stock | S - Open market or private sale | -1,711 | $16.53 |
Mar 7/24 | Mar 5/24 | Gad Thomas | Direct Ownership | Common Stock | S - Open market or private sale | -3,900 | $16.44 |
Mar 7/24 | Mar 5/24 | Smith Susan Laura | Direct Ownership | Common Stock | S - Open market or private sale | -1,682 | $16.55 |
Feb 14/24 | Feb 12/24 | Rossi Michael J | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 54,000 | |
Feb 14/24 | Feb 12/24 | Rossi Michael J | Direct Ownership | Employee Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 214,200 | |
Feb 14/24 | Feb 12/24 | Rossi Michael J | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 35,700 | |
Jan 22/24 | Jan 18/24 | Rajah Vignesh | Direct Ownership | Employee Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 35,700 | |
Jan 22/24 | Jan 18/24 | Rajah Vignesh | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 17,800 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for YMAB within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 14/24 | Mar 12/24 | Tagliaferri Mary | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 27,900 | |
Mar 14/24 | Mar 12/24 | Tagliaferri Mary | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 4,660 | |
Mar 7/24 | Mar 5/24 | Rajah Vignesh | Direct Ownership | Common Stock | S - Open market or private sale | -1,711 | $16.53 |
Mar 7/24 | Mar 5/24 | Gad Thomas | Direct Ownership | Common Stock | S - Open market or private sale | -3,900 | $16.44 |
Mar 7/24 | Mar 5/24 | Smith Susan Laura | Direct Ownership | Common Stock | S - Open market or private sale | -1,682 | $16.55 |
Feb 14/24 | Feb 12/24 | Rossi Michael J | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 54,000 | |
Feb 14/24 | Feb 12/24 | Rossi Michael J | Direct Ownership | Employee Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 214,200 | |
Feb 14/24 | Feb 12/24 | Rossi Michael J | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 35,700 | |
Jan 22/24 | Jan 18/24 | Rajah Vignesh | Direct Ownership | Employee Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 35,700 | |
Jan 22/24 | Jan 18/24 | Rajah Vignesh | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 17,800 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |